Overview

Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Phase : Phase III Indication : Erectile Dysfunction Study Design : open-label, fixed dose, 6-month extension study (parent study : DA8159_EDD_III)
Phase:
Phase 3
Details
Lead Sponsor:
Dong-A Pharmaceutical Co., Ltd.
Treatments:
Udenafil